Top Industry Leaders in the DPT vaccine Market
Latest DPT Vaccine Companies Update
Merck & Co., a major player, partners with Thermos to develop innovative vaccines and immune-modulation therapies for certain infections, including diphtheria and tetanus. This collaboration leverages Thermos' expertise in cold chain technology for vaccine storage and distribution, aiming to improve access to these vital vaccines in underserved regions.
Sanofi Pasteur, another key player, launches its Hexacima® vaccine in the United States, offering a six-in-one vaccine for infants that combines protection against diphtheria, tetanus, pertussis, polio, hepatitis B, and Haemophilus influenzae type b (Hib). This new option provides broader immunization coverage in a single shot.
China National Pharmaceutical Group (CNPG) receives WHO prequalification for its DT vaccine, marking a significant step towards wider global access to this essential vaccine produced by a Chinese company. This could contribute to improved vaccination rates and disease control in developing countries.
List of DPT Vaccine Key Companies in the Market
- Merck and Co of the United States region
- Chiron Pharmaceutical Pvt Ltd of India
- Sanofi of France
- Wyeth of the United States
- GSK of the United States
- Serum Institute of India Pvt Ltd
- Panacea Biotec Ltd
- Johnson and Johnson
- Bionet-Asia
- Meiji Holdings Co. Ltd
- Lanzhou Institute of biological products of the Chinese region